http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-4520283-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cdb48bb3f81c7acc4f9d4dc306fd3b4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-14
filingDate 1994-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_914f0162d45f1661c9bb6a9e9e78f630
publicationDate 1997-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-4520283-A1
titleOfInvention ANTIVIRAL AGENTS
abstract 1. THE USE OF A FLAVINE, A DERIVATIVE OF IT, OR OF A MIXTURE COMPRISING TWO OR MORE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF PROPHYLAXIS OR THERAPY OF DISEASES CAUSED BY VIRUS INFECTION. 11. A FLAVINE OR FLAVINE DERIVATIVE FOR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT USEFUL IN THE TREATMENT OF PORPHILAXIS OR THERAPY OF DISEASES CAUSED BY VIRUS INFECTION. 13. A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROPHYLAXIS OR THERAPY OF DISEASES CAUSED BY VIROSIC INFECTION, CHARACTERIZING THE COMPOSITION BECAUSE IT INCLUDES A FLAVINE OR FLAVINE DERIVATIVE. 20. A RECEPTACLE FOR IMMEDIATE PHARMACEUTICAL CONTAINMENT PRIOR TO ADMINISTRATION, BEING MANIPULABLE SUCH RECEPTACLE IN A MEDICATION ADMINISTRATION PROCESS BY CONTAINING A FLAVINE OR DERIVATIVE FROM A FLAVINE OR DERIVATIVE FROM FLAVINE. PATIENT OR A DEVICE OF A REPRESENTATION OF INSTRUCTIONS FOR THE USE OF FLAVINE OR FLAVINE DERIVATIVE AS A MEDICATION IN THE TREATMENT FOR PROPHYLAXIS OR THERAPY OF DISEASES CAUSED BY VIROSIC INFECTIONS. 21. THE COMBINATION OF: (a) A FLAVINE OR A DERIVATIVE OF FLAVINE FORMULATED FOR PHARMACEUTICAL USE, AND (b) INSTRUCTIONS FOR THE USE OF SUCH FLAVINE OR DERIVATIVE OF FLAVINE FORMULATED FOR THE MANUFACTURE OF A MEDICINAL PRODUCT INTENDED FOR TREATMENT BY TERA - PIA OR PROPHYLAXIS OF DISEASES CAUSED BY VIROSIC INFECTIONS OR FOR USE IN SUCH TREATMENT. 24. A PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF VIROSIC INFECTIONS, PROCEDURES THAT INCLUDE THE FORMULATION OF A FLAVINE, SUCH AS RIBOFLAVINA OR A DERIVATIVE OF IT, FOR ANTIVIROSIC USE. .
priorityDate 1993-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450281383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553045

Total number of triples: 25.